Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 2
1996 1
1998 1
2006 1
2007 2
2010 1
2011 1
2012 2
2013 2
2014 1
2019 3
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction.
Hambley BC, Norsworthy KJ, Jasem J, Zimmerman JW, Shenderov E, Webster JA, Showel MM, Gondek LP, Dalton WB, Prince G, Gladstone DE, Streiff MB, Pratz KW, Gojo I, Ghiaur G, Levis MJ, Smith BD, DeZern AE. Hambley BC, et al. Among authors: zimmerman jw. Leuk Res. 2019 Aug;83:106174. doi: 10.1016/j.leukres.2019.106174. Epub 2019 Jun 21. Leuk Res. 2019. PMID: 31255938 Clinical Trial. No abstract available.
Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes.
Balaji A, Zhang J, Wills B, Marrone KA, Elmariah H, Yarchoan M, Zimmerman JW, Hajjir K, Venkatraman D, Armstrong DK, Laheru DA, Mehra R, Ho WJ, Reuss JE, Heng J, Vellanki P, Donehower RC, Holdhoff M, Naidoo J. Balaji A, et al. Among authors: zimmerman jw. J Oncol Pract. 2019 Sep;15(9):e825-e834. doi: 10.1200/JOP.18.00703. Epub 2019 Aug 6. J Oncol Pract. 2019. PMID: 31386608 Free PMC article.
Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer.
Seppälä TT, Zimmerman JW, Sereni E, Plenker D, Suri R, Rozich N, Blair A, Thomas DL 2nd, Teinor J, Javed A, Patel H, Cameron JL, Burns WR, He J, Tuveson DA, Jaffee EM, Eshleman J, Szabolcs A, Ryan DP, Ting DT, Wolfgang CL, Burkhart RA. Seppälä TT, et al. Among authors: zimmerman jw. Ann Surg. 2020 Jul 9. doi: 10.1097/SLA.0000000000004200. Online ahead of print. Ann Surg. 2020. PMID: 32657929
Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Cav3.2 T-type voltage-gated calcium channels and Ca2+ influx.
Jimenez H, Wang M, Zimmerman JW, Pennison MJ, Sharma S, Surratt T, Xu ZX, Brezovich I, Absher D, Myers RM, DeYoung B, Caudell DL, Chen D, Lo HW, Lin HK, Godwin DW, Olivier M, Ghanekar A, Chen K, Miller LD, Gong Y, Capstick M, D'Agostino RB Jr, Munden R, Merle P, Barbault A, Blackstock AW, Bonkovsky HL, Yang GY, Jin G, Liu L, Zhang W, Watabe K, Blackman CF, Pasche BC. Jimenez H, et al. Among authors: zimmerman jw. EBioMedicine. 2019 Jun;44:209-224. doi: 10.1016/j.ebiom.2019.05.034. Epub 2019 May 31. EBioMedicine. 2019. PMID: 31160272 Free PMC article.
Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies.
Zimmerman JW, Jimenez H, Pennison MJ, Brezovich I, Morgan D, Mudry A, Costa FP, Barbault A, Pasche B. Zimmerman JW, et al. Chin J Cancer. 2013 Nov;32(11):573-81. doi: 10.5732/cjc.013.10177. Chin J Cancer. 2013. PMID: 24206915 Free PMC article. Review.
Cancer cell proliferation is inhibited by specific modulation frequencies.
Zimmerman JW, Pennison MJ, Brezovich I, Yi N, Yang CT, Ramaker R, Absher D, Myers RM, Kuster N, Costa FP, Barbault A, Pasche B. Zimmerman JW, et al. Br J Cancer. 2012 Jan 17;106(2):307-13. doi: 10.1038/bjc.2011.523. Epub 2011 Dec 1. Br J Cancer. 2012. PMID: 22134506 Free PMC article.
SMAD4 is a potential prognostic marker in human breast carcinomas.
Liu NN, Xi Y, Callaghan MU, Fribley A, Moore-Smith L, Zimmerman JW, Pasche B, Zeng Q, Li YL. Liu NN, et al. Among authors: zimmerman jw. Tumour Biol. 2014 Jan;35(1):641-50. doi: 10.1007/s13277-013-1088-1. Epub 2013 Aug 24. Tumour Biol. 2014. PMID: 23975369 Free PMC article.
Discharge-driven electric oxygen-iodine laser superlinear enhancement via increasing g0L.
Benavides GF, Zimmerman JW, Woodard BS, Day MT, King DM, Carroll DL, Palla AD, Verdeyen JT, Solomon WC. Benavides GF, et al. Among authors: zimmerman jw. Opt Lett. 2012 May 1;37(9):1409-11. doi: 10.1364/OL.37.001409. Opt Lett. 2012. PMID: 22555687
Enhancement of electric oxygen-iodine laser performance using larger mode volume resonators.
Woodard BS, Benavides GF, Zimmerman JW, Carroll DL, Palla AD, Day MT, Verdeyen JT, Solomon WC. Woodard BS, et al. Among authors: zimmerman jw. Opt Lett. 2010 May 15;35(10):1611-3. doi: 10.1364/OL.35.001611. Opt Lett. 2010. PMID: 20479825
Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development.
Chu NJ, Anders RA, Fertig EJ, Cao M, Hopkins AC, Keenan BP, Popovic A, Armstrong TD, Jaffee EM, Zimmerman JW. Chu NJ, et al. Among authors: zimmerman jw. Cancer Prev Res (Phila). 2020 Jul;13(7):569-582. doi: 10.1158/1940-6207.CAPR-20-0053. Epub 2020 May 14. Cancer Prev Res (Phila). 2020. PMID: 32409593
17 results
Jump to page
Feedback